Egenskap
Anorexia
Lack of desire to eat (loss of appetite).
Sammendrag
- Også kalt
- Deliberately not eating, Obsessive dieting, Refusing to eat
- Kroppssystem
- Abnormality of the digestive system
ReferansegenomGRCh38hg38
Posisjoner på gen- og variantsidene følger dette valget i denne nettleseren.
Read the genes linked to Anorexia, and the rest of your genome, with one test.
Fra 449 $Gratis frakt · Resultater på 6–8 uker
Få mitt Genome Test132 gener knyttet til Anorexia
Endringer i disse genene forårsaker sjeldne tilstander der Anorexia forekommer. De fleste med denne egenskapen har ingen av disse tilstandene, og et gen på denne listen sier ingenting om noens eget genom.
| Gen | Hvor ofte den forekommer | Tilstander |
|---|---|---|
| ITPR3inositol 1,4,5-trisphosphate receptor type 3 | Alltid | I 1 tilstand |
| NFS1NFS1 cysteine desulfurase | Alltid | I 1 tilstand |
| PTCRApre T cell antigen receptor alpha | Alltid | I 1 tilstand |
| BANK1B cell scaffold protein with ankyrin repeats 1 | Svært ofte (80–99 %) | I 1 tilstand |
| BLKBLK proto-oncogene, Src family tyrosine kinase | Svært ofte (80–99 %) | I 1 tilstand |
| BRCA1BRCA1 DNA repair associated | Svært ofte (80–99 %) | I 2 tilstander |
| BRCA2BRCA2 DNA repair associated | Svært ofte (80–99 %) | I 2 tilstander |
| C4Acomplement C4A (Chido/Rodgers blood group) | Svært ofte (80–99 %) | I 2 tilstander |
| C4Bcomplement C4B (Chido/Rodgers blood group) | Svært ofte (80–99 %) | I 1 tilstand |
| CD4CD4 molecule | Svært ofte (80–99 %) | I 1 tilstand |
| CDKN2Acyclin dependent kinase inhibitor 2A | Svært ofte (80–99 %) | I 1 tilstand |
| CR2complement C3d receptor 2 | Svært ofte (80–99 %) | I 1 tilstand |
| CTLA4cytotoxic T-lymphocyte associated protein 4 | Svært ofte (80–99 %) | I 1 tilstand |
| DNASE1deoxyribonuclease 1 | Svært ofte (80–99 %) | I 1 tilstand |
| ETS1ETS proto-oncogene 1, transcription factor | Svært ofte (80–99 %) | I 1 tilstand |
| FCGR2BFc gamma receptor IIb | Svært ofte (80–99 %) | I 1 tilstand |
| FCGR3BFc gamma receptor IIIb | Svært ofte (80–99 %) | I 1 tilstand |
| GBA1glucosylceramidase beta 1 | Svært ofte (80–99 %) | I 1 tilstand |
| HLA-Bmajor histocompatibility complex, class I, B | Svært ofte (80–99 %) | I 3 tilstander |
| HLA-DRB1major histocompatibility complex, class II, DR beta 1 | Svært ofte (80–99 %) | I 3 tilstander |
| HLCSholocarboxylase synthetase | Svært ofte (80–99 %) | I 1 tilstand |
| IGHG1immunoglobulin heavy constant gamma 1 (G1m marker) | Svært ofte (80–99 %) | I 1 tilstand |
| IL10interleukin 10 | Svært ofte (80–99 %) | I 2 tilstander |
| IRAK1interleukin 1 receptor associated kinase 1 | Svært ofte (80–99 %) | I 1 tilstand |
| IRF4interferon regulatory factor 4 | Svært ofte (80–99 %) | I 1 tilstand |
| IRF5interferon regulatory factor 5 | Svært ofte (80–99 %) | I 1 tilstand |
| ITGAMintegrin subunit alpha M | Svært ofte (80–99 %) | I 1 tilstand |
| JAZF1JAZF zinc finger 1 | Svært ofte (80–99 %) | I 1 tilstand |
| KIAA0319LKIAA0319 like | Svært ofte (80–99 %) | I 1 tilstand |
| KRASKRas proto-oncogene, GTPase | Svært ofte (80–99 %) | I 1 tilstand |
| MECP2methyl-CpG binding protein 2 | Svært ofte (80–99 %) | I 2 tilstander |
| MMADHCmetabolism of cobalamin associated D | Svært ofte (80–99 %) | I 1 tilstand |
| MMUTmethylmalonyl-CoA mutase | Svært ofte (80–99 %) | I 1 tilstand |
| P4HA2prolyl 4-hydroxylase subunit alpha 2 | Svært ofte (80–99 %) | I 1 tilstand |
| PALB2partner and localizer of BRCA2 | Svært ofte (80–99 %) | I 1 tilstand |
| PALLDpalladin, cytoskeletal associated protein | Svært ofte (80–99 %) | I 1 tilstand |
| PDCD1programmed cell death 1 | Svært ofte (80–99 %) | I 1 tilstand |
| PTPN22protein tyrosine phosphatase non-receptor type 22 | Svært ofte (80–99 %) | I 2 tilstander |
| PXKPX domain containing serine/threonine kinase like | Svært ofte (80–99 %) | I 1 tilstand |
| RABL3RAB, member of RAS oncogene family like 3 | Svært ofte (80–99 %) | I 1 tilstand |
Vis 92 gener til
| Gen | Hvor ofte den forekommer | Tilstander |
|---|---|---|
| SCARB2scavenger receptor class B member 2 | Svært ofte (80–99 %) | I 1 tilstand |
| SLC19A2solute carrier family 19 member 2 | Svært ofte (80–99 %) | I 1 tilstand |
| SLC46A1solute carrier family 46 member 1 | Svært ofte (80–99 %) | I 1 tilstand |
| SMAD4SMAD family member 4 | Svært ofte (80–99 %) | I 1 tilstand |
| SPP1secreted phosphoprotein 1 | Svært ofte (80–99 %) | I 1 tilstand |
| STAT4signal transducer and activator of transcription 4 | Svært ofte (80–99 %) | I 2 tilstander |
| TLR7toll like receptor 7 | Svært ofte (80–99 %) | I 1 tilstand |
| TNFAIP3TNF alpha induced protein 3 | Svært ofte (80–99 %) | I 1 tilstand |
| TNFSF4TNF superfamily member 4 | Svært ofte (80–99 %) | I 1 tilstand |
| TNIP1TNFAIP3 interacting protein 1 | Svært ofte (80–99 %) | I 1 tilstand |
| TP53tumor protein p53 | Svært ofte (80–99 %) | I 1 tilstand |
| TREX1three prime repair exonuclease 1 | Svært ofte (80–99 %) | I 1 tilstand |
| UBE2L3ubiquitin conjugating enzyme E2 L3 | Svært ofte (80–99 %) | I 1 tilstand |
| AQP2aquaporin 2 | Ofte (30–79 %) | I 1 tilstand |
| ASXL1ASXL transcriptional regulator 1 | Ofte (30–79 %) | I 1 tilstand |
| ATMATM serine/threonine kinase | Ofte (30–79 %) | I 1 tilstand |
| ATP1A2ATPase Na+/K+ transporting subunit alpha 2 | Ofte (30–79 %) | I 1 tilstand |
| ATP1A3ATPase Na+/K+ transporting subunit alpha 3 | Ofte (30–79 %) | I 1 tilstand |
| ATRXATRX chromatin remodeler | Ofte (30–79 %) | I 1 tilstand |
| AVPR2arginine vasopressin receptor 2 | Ofte (30–79 %) | I 1 tilstand |
| BCORBCL6 corepressor | Ofte (30–79 %) | I 1 tilstand |
| CACNA1Acalcium voltage-gated channel subunit alpha1 A | Ofte (30–79 %) | I 1 tilstand |
| CBLCbl proto-oncogene | Ofte (30–79 %) | I 1 tilstand |
| CCND1cyclin D1 | Ofte (30–79 %) | I 1 tilstand |
| FIP1L1factor interacting with PAPOLA and CPSF1 | Ofte (30–79 %) | I 1 tilstand |
| GLAgalactosidase alpha | Ofte (30–79 %) | I 1 tilstand |
| HMGCL3-hydroxy-3-methylglutaryl-CoA lyase | Ofte (30–79 %) | I 1 tilstand |
| IGHimmunoglobulin heavy locus | Ofte (30–79 %) | I 1 tilstand |
| IL12Binterleukin 12B | Ofte (30–79 %) | I 1 tilstand |
| IRF2BP2interferon regulatory factor 2 binding protein 2 | Ofte (30–79 %) | I 1 tilstand |
| MC2Rmelanocortin 2 receptor | Ofte (30–79 %) | I 1 tilstand |
| MLXMAX dimerization protein MLX | Ofte (30–79 %) | I 1 tilstand |
| MRAPmelanocortin 2 receptor accessory protein | Ofte (30–79 %) | I 1 tilstand |
| MT-TL2mitochondrially encoded tRNA-Leu (CUN) 2 | Ofte (30–79 %) | I 1 tilstand |
| NABP1nucleic acid binding protein 1 | Ofte (30–79 %) | I 1 tilstand |
| NAGSN-acetylglutamate synthase | Ofte (30–79 %) | I 1 tilstand |
| NNTnicotinamide nucleotide transhydrogenase | Ofte (30–79 %) | I 1 tilstand |
| NPM1nucleophosmin 1 | Ofte (30–79 %) | I 1 tilstand |
| NUMA1nuclear mitotic apparatus protein 1 | Ofte (30–79 %) | I 1 tilstand |
| OTCornithine transcarbamylase | Ofte (30–79 %) | I 1 tilstand |
| PMLPML nuclear body scaffold | Ofte (30–79 %) | I 1 tilstand |
| PRKAR1Aprotein kinase cAMP-dependent type I regulatory subunit alpha | Ofte (30–79 %) | I 1 tilstand |
| RARAretinoic acid receptor alpha | Ofte (30–79 %) | I 1 tilstand |
| RHOBTB2Rho related BTB domain containing 2 | Ofte (30–79 %) | I 1 tilstand |
| RUNX1RUNX family transcription factor 1 | Ofte (30–79 %) | I 1 tilstand |
| SCN2Asodium voltage-gated channel alpha subunit 2 | Ofte (30–79 %) | I 1 tilstand |
| SLC1A3solute carrier family 1 member 3 | Ofte (30–79 %) | I 1 tilstand |
| SLC2A1solute carrier family 2 member 1 | Ofte (30–79 %) | I 1 tilstand |
| SRSF2serine and arginine rich splicing factor 2 | Ofte (30–79 %) | I 1 tilstand |
| STARsteroidogenic acute regulatory protein | Ofte (30–79 %) | I 1 tilstand |
| STAT3signal transducer and activator of transcription 3 | Ofte (30–79 %) | I 1 tilstand |
| STAT5Bsignal transducer and activator of transcription 5B | Ofte (30–79 %) | I 1 tilstand |
| TBL1XR1TBL1X/Y related 1 | Ofte (30–79 %) | I 1 tilstand |
| TET2tet methylcytosine dioxygenase 2 | Ofte (30–79 %) | I 2 tilstander |
| TXNRD2thioredoxin reductase 2 | Ofte (30–79 %) | I 1 tilstand |
| ZBTB16zinc finger and BTB domain containing 16 | Ofte (30–79 %) | I 1 tilstand |
| ACAT1acetyl-CoA acetyltransferase 1 | Noen ganger (5–29 %) | I 1 tilstand |
| CALRcalreticulin | Noen ganger (5–29 %) | I 1 tilstand |
| CBScystathionine beta-synthase | Noen ganger (5–29 %) | I 1 tilstand |
| CCR1C-C motif chemokine receptor 1 | Noen ganger (5–29 %) | I 1 tilstand |
| CD247CD247 molecule | Noen ganger (5–29 %) | I 1 tilstand |
| CD3DCD3 delta subunit of T-cell receptor complex | Noen ganger (5–29 %) | I 1 tilstand |
| CD3ECD3 epsilon subunit of T-cell receptor complex | Noen ganger (5–29 %) | I 1 tilstand |
| CDKN1Bcyclin dependent kinase inhibitor 1B | Noen ganger (5–29 %) | I 1 tilstand |
| CDKN2Bcyclin dependent kinase inhibitor 2B | Noen ganger (5–29 %) | I 1 tilstand |
| ERAP1endoplasmic reticulum aminopeptidase 1 | Noen ganger (5–29 %) | I 1 tilstand |
| FASFas cell surface death receptor | Noen ganger (5–29 %) | I 1 tilstand |
| FLI1Fli-1 proto-oncogene, ETS transcription factor | Noen ganger (5–29 %) | I 1 tilstand |
| IFNGR1interferon gamma receptor 1 | Noen ganger (5–29 %) | I 2 tilstander |
| IL12Ainterleukin 12A | Noen ganger (5–29 %) | I 1 tilstand |
| IL12A-AS1IL12A antisense RNA 1 | Noen ganger (5–29 %) | I 1 tilstand |
| IL23Rinterleukin 23 receptor | Noen ganger (5–29 %) | I 1 tilstand |
| JAK2Janus kinase 2 | Noen ganger (5–29 %) | I 1 tilstand |
| KLRC4killer cell lectin like receptor C4 | Noen ganger (5–29 %) | I 1 tilstand |
| MEFVMEFV innate immunity regulator, pyrin | Noen ganger (5–29 %) | I 1 tilstand |
| MEN1menin 1 | Noen ganger (5–29 %) | I 1 tilstand |
| MPLMPL proto-oncogene, thrombopoietin receptor | Noen ganger (5–29 %) | I 1 tilstand |
| MYD88MYD88 innate immune signal transduction adaptor | Noen ganger (5–29 %) | I 1 tilstand |
| PKHD1PKHD1 ciliary IPT domain containing fibrocystin/polyductin | Noen ganger (5–29 %) | I 1 tilstand |
| PTPN3protein tyrosine phosphatase non-receptor type 3 | Noen ganger (5–29 %) | I 1 tilstand |
| ROS1ROS proto-oncogene 1, receptor tyrosine kinase | Noen ganger (5–29 %) | I 1 tilstand |
| SDHAsuccinate dehydrogenase complex flavoprotein subunit A | Noen ganger (5–29 %) | I 1 tilstand |
| SDHBsuccinate dehydrogenase complex iron sulfur subunit B | Noen ganger (5–29 %) | I 1 tilstand |
| SDHCsuccinate dehydrogenase complex subunit C | Noen ganger (5–29 %) | I 1 tilstand |
| SLC39A4solute carrier family 39 member 4 | Noen ganger (5–29 %) | I 1 tilstand |
| SYKspleen associated tyrosine kinase | Noen ganger (5–29 %) | I 1 tilstand |
| TGFB1transforming growth factor beta 1 | Noen ganger (5–29 %) | I 1 tilstand |
| TLR4toll like receptor 4 | Noen ganger (5–29 %) | I 1 tilstand |
| UBAC2UBA domain containing 2 | Noen ganger (5–29 %) | I 1 tilstand |
| ALPLalkaline phosphatase, biomineralization associated | Ikke registrert | I 1 tilstand |
| ARG1arginase 1 | Ikke registrert | I 1 tilstand |
| SLC4A1solute carrier family 4 member 1 (Diego blood group) | Ikke registrert | I 1 tilstand |
Hvor ofte dette forekommer hos personer med en av genets tilstander, oppgitt som den hyppigste forekomsten blant dem, slik Human Phenotype Ontology registrerer den. Disse sidene beskriver egenskaper og forskningen bak dem. De er ikke en diagnose, og om symptomer bør du spørre lege eller genetisk rådgiver.
Bredere egenskaper
Slik er informasjonen samlet
- Human Phenotype Ontology, versjon 2026-09-01: egenskapen, navnene på den, definisjonen og genene som er knyttet til den. Les mer på hpo.jax.org.
- Datautgave 2026.10.16-c6eea6bf.
Én test. En livstid med svar.
Fra 449 $Gratis frakt · Resultater på 6–8 uker